Natixis Investment Managers International’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $224K | Buy |
2,883
+352
| +14% | +$27.4K | 0.02% | 130 |
|
|
2024
Q3 | $170K | Sell |
2,531
-273,965
| -99% | -$18.4M | 0.01% | 137 |
|
|
2024
Q2 | $31.3M | Buy |
276,496
+34,005
| +14% | +$3.86M | 2.34% | 19 |
|
|
2024
Q1 | $33.6M | Buy |
242,491
+22,853
| +10% | +$3.17M | 2.29% | 20 |
|
|
2023
Q4 | $27.3M | Sell |
219,638
-22,094
| -9% | -$2.74M | 1.93% | 22 |
|
|
2023
Q3 | $22.6M | Buy |
241,732
+238,844
| +8,270% | +$22.3M | 1.74% | 27 |
|
|
2023
Q2 | $371K | Buy |
2,888
+63
| +2% | +$8.1K | 0.03% | 101 |
|
|
2023
Q1 | $328K | Sell |
2,825
-563
| -17% | -$65.4K | 0.02% | 110 |
|
|
2022
Q4 | $384K | Sell |
3,388
-1,250
| -27% | -$142K | 0.03% | 111 |
|
|
2022
Q3 | $373K | Sell |
4,638
-11,662
| -72% | -$938K | 0.03% | 99 |
|
|
2022
Q2 | $1.21M | Buy |
16,300
+10,564
| +184% | +$787K | 0.02% | 192 |
|
|
2022
Q1 | $733K | Buy |
5,736
+3,336
| +139% | +$426K | 0.01% | 251 |
|
|
2021
Q4 | $322K | Buy |
2,400
+320
| +15% | +$42.9K | 0.02% | 115 |
|
|
2021
Q3 | $284K | Sell |
2,080
-120
| -5% | -$16.4K | 0.02% | 131 |
|
|
2021
Q2 | $234K | Buy |
2,200
+580
| +36% | +$61.7K | 0.01% | 152 |
|
|
2021
Q1 | $145K | Sell |
1,620
-64
| -4% | -$5.73K | 0.01% | 198 |
|
|
2020
Q4 | $155K | Buy |
+1,684
| New | +$155K | 0.01% | 205 |
|
|
2017
Q4 | – | Sell |
-11,840
| Closed | -$145K | – | 225 |
|
|
2017
Q3 | $145K | Buy |
+11,840
| New | +$145K | 0.01% | 339 |
|